<p>This is a $299,961.00 SBIR Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Cubit Diagnostics, Inc. (doing business as Arete Biosciences) for the development of an ultrasensitive, rapid, and easy-to-use at-home molecular test for Hepatitis C, Hepatitis B, and HIV. The contract has a firm fixed price and a completion date of April 30, 2025. It is designated as a Total Small Business set-aside contract.</p>
This is a $299,408 SBIR Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Darwin Biosciences, Inc., a woman-owned small business. The contract is for the development of rapid diagnostic assays for self-monitoring of acute or rebound HIV-1 infection. As a Small Business Innovation Research (SBIR) award, this contract is set aside for small businesses. The contract has a firm fixed price structure and a period of performance...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services, to Accelevir Diagnostics LLC, a woman-owned small business. The contract, valued at $299,975.00, is for the company to adapt its Intact Proviral DNA Assay (IPDA) to measure latent HIV-1 for individuals with the CRF-1_AE genetic subtype of the virus. This contract is part of NIAID's Small Business Innovation Research (SBIR)...
This $1,799,981 federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Baebies, Inc., a small business manufacturer of medical diagnostic equipment. The contract is for the development of a point-of-care digital microfluidic platform to diagnose hepatitis C virus (HCV) infection and confirm cure following treatment. This work falls under the Small Business Innovation Research (SBIR) program, which...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $306,206.00 firm fixed-price Small Business Innovation Research (SBIR) Phase I contract to Intuitive Biosciences Inc., a small disadvantaged business, to develop "THE EV-HIV ASSAY, A POINT-OF-CARE LATERAL FLOW IMMUNOASSAY TO ACCURATELY IDENTIFY HIV INFECTION FROM BLOOD-BASED EXTRACELLULAR VESICLES." This contract is linked to a broader SBIR solicitation issued by the NIAID and Centers for Disease Control...
This is a $2,299,958.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Baebies, Inc., a small business manufacturer of medical diagnostic equipment and devices. The contract is for the development of a "SIMPLE MULTIPLEXED PLATFORM FOR SELF-ADMINISTERED HIV AND HEPATITIS B TESTING" under the SBIR Program Phase I. As a small business contractor, Baebies has prior...
This $300,000.00 Small Business Innovation Research (SBIR) Phase I contract was awarded by the Department of Health and Human Services' (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Avantgen Inc., a small biotechnology company based in San Diego, California. The contract is for the development of a rapid and point-of-care diagnostic kit for the detection of the hepatitis C virus. This award is part of NIAID's solicitation for...
The Department of Health and Human Services, National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Phase I contract to Fluid Discovery, Inc., a for-profit small business, to develop "Multiplexed Droplet Digital Nucleic Acid Amplification Technologies for HIV Diagnosis." The $299,903 firm-fixed-price contract, which runs through July 31, 2024, supports research and development of innovative...
This is a $299,968 firm fixed-price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Vitruvian Bio, LLC, a small disadvantaged, woman-owned business. The contract is for developing an electrochemical self-monitoring device for rapid nucleic acid-based testing of HIV-1 under the Small Business Innovation Research (SBIR) program. This contract is set aside for small businesses and is focused on...
This is a $2,299,994.00 Phase I Small Business Innovation Research (SBIR) contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Department of Health and Human Services, to Baebies, Inc., a small business manufacturer of medical diagnostic equipment. The contract is for the development of a "MULTIFUNCTIONAL POINT-OF-CARE PLATFORM TO DIFFERENTIATE HIV INFECTION FROM VACCINE INDUCED SEROPOSITIVITY", which aligns with NIAID's interests in...